Rocket Pharmaceuticals, Inc.
RCKT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$50,332 | -$68,919 | -$61,334 | -$60,327 |
| Dep. & Amort. | $3,240 | $2,579 | $2,989 | $2,361 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $10,857 | $0 | $0 |
| Change in WC | -$11,496 | $8,731 | -$5,713 | -$732 |
| Other Non-Cash | $8,160 | -$2,212 | $8,256 | $11,741 |
| Operating Cash Flow | -$50,428 | -$48,964 | -$55,802 | -$46,957 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $54 | -$50 | -$364 | -$309 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$29,438 | -$52,689 | -$139,931 | -$124,045 |
| Inv. Sales/Matur. | $123,000 | $84,500 | $82,260 | $86,483 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $93,616 | $31,761 | -$58,035 | -$37,871 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $8 | $13 | $12 | $15 |
| Stock Issued | $0 | $215 | $0 | $182,849 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$67 | -$13 | $0 | $0 |
| Financing Cash Flow | -$59 | $215 | $12 | $182,864 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $43,129 | -$16,988 | -$113,825 | $98,036 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $32,819 | $51,172 | $163,635 | $65,599 |
| End Cash | $75,948 | $34,184 | $49,810 | $163,635 |
| Free Cash Flow | -$50,374 | -$49,014 | -$56,166 | -$47,266 |